Page 10 - Toddler Development News Today

/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced positive interim results from the ongoing RAINBOWFISH trial that demonstrated...

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced new interim data from two studies of Evrysdi® (risdiplam); JEWELFISH and RAINBOWFISH. Data from JEWELFISH, an ongoing open-label study primarily evaluating the safety of Evrysdi in people aged 1 to 60 years who have been previously treated with another ...

Language skills of 2-year-olds whose moms took anti-epilepsy drugs during pregnancy are similar to those with healthy mothers.

Infant gut microbiota associated with fine motor skills The microbial landscape of a childs gut may impact their fine motor skills, representing a potential opportunity for probiotic interventions relevant to treatment for motor disorders, according to a new study. The assembly of the gut microbiota starts from birth, characterised by a rapid rate of colonisation and expansion of gut bacteria dominated by  Actinobacteria​ and  Firmicutes​ and  Bacteroidetes�...

Is it safe? Parents worry about risks as schools, camps reopen TODAY 5/10/2021 Lisa Tolin Don’t touch that. Wash your hands for 30 seconds. Where’s your mask? Six feet, please. Parents who spent the last year carefully protecting their children from the COVID-19 pandemic are now being asked to send them back to daycare, school and camps, all without the benefit of vaccines. Its cause for celebration, but also, for many, worry. As life resumes some normal rhythms, the world...

iii MISSISSAUGA, ON, April 15, 2021 /CNW/ - Hoffmann-La Roche Limited (Roche Canada) today announced that Health Canada has granted EVRYSDI Ⓡ (risdiplam) market authorization for the treatment of spinal muscular atrophy (SMA) in patients two months of age or older. iii EVRYSDI works by helping the body make more of a protein called, "SMN protein." EVRYSDI increases and sustains the amount of SMN protein in the body, which helps to treat SMA. It is the first medicine for SMA that can be taken ...

Share: More than twice as many babies (61% vs. 29%) were able to sit without support for at least five seconds after 24 months compared to 12 months of treatment Evrysdi increased survival and reduced need for permanent ventilation Evrysdi has proven efficacy across adults, children and babies 2 months and older Basel, 15 April 2021 - Roche ((SIX: RO, ROG, OTCQX:RHHBY) today announced new 2-year data from Part 2 of FIREFISH, a Phase 2/3 global study evaluating Evrysdi™ (risdiplam) in infants ...

F. Hoffmann-La Roche Ltd: Roches Evrysdi continues to improve motor function and survival in babies with Type 1 Spinal Muscular Atrophy (SMA) Evrysdi increased survival and reduced need for permanent ventilation Evrysdi has proven efficacy across adults, children and babies 2 months and older Basel, 15 April 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced new 2-year data from Part 2 of FIREFISH, a Phase 2/3 global study evaluating Evrysdi (risdiplam) in infants aged 1-7 months at enro...

Press release content from Business Wire. The AP news staff was not involved in its creation. New Genentech Data at 2021 AAN Highlight Impact and Breadth of Expanding Neuroscience Portfolio April 8, 2021 GMT SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Apr 8, 2021-- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that new data for its approved and investigational medicines for the treatment of neurological disorders will be presented at the 73rd American Ac...

Is Shelter-in-Place Affecting My Toddlers Language Development? Heres What Experts Say 3 Shares My youngest son recently turned 2, which means half of his life has happened during the COVID-19 pandemic. The shelter-in-place rules and COVID-19 precautions my family have taken meant that he couldnt have playdates, see his friends at nursery, or go to many of the fun toddler social places — like indoor playgrounds, childrens museums, or tumbling classes — for a year. While he has adjusted lik...